GRUNENTHAL GMBH
🏢 View company profile →33Patents
15Active
33Granted
43Portfolio score
Filing activity: Dec 12, 1977 → Nov 21, 2017 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7776314B2 | Abuse-proofed dosage system | Human Necessities | 295 | Active |
| US8309060B2 | Abuse-proofed dosage form | Human Necessities | 202 | Active |
| US8192722B2 | Abuse-proof dosage form | Human Necessities | 131 | Active |
| US8420056B2 | Abuse-proofed dosage form | Human Necessities | 51 | Active |
| US7611730B2 | Tramadol-based medicament | Human Necessities | 43 | Expired |
| US7141695B2 | Methods for producing substituted acrylic acid esters and use of the latter for producing substituted γ-amino acids | Chemistry; Metallurgy | 20 | Expired |
| US6875447B2 | Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt | Human Necessities | 19 | Expired |
| US7838034B2 | Intravenous pharmaceutical form of administration | Human Necessities | 15 | Expired |
| US6956055B2 | Substituted γ-lactone compounds as NMDA-antagonists | Chemistry; Metallurgy | 12 | Expired |
| US4845076A | DNA sequences coding for proteins having the biological activity of HUSI-type I inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | Human Necessities | 12 | Expired |
| US7109214B2 | Substituted cyclopentene compounds | Chemistry; Metallurgy | 10 | Expired |
| US7041662B2 | Substituted benzo [b] azepin-2-one compounds | Human Necessities | 7 | Expired |
| US6943181B2 | Use of substituted gamma-lactone compounds as pharmaceutical preparations | Human Necessities | 5 | Expired |
| US8293758B2 | Substituted spirocyclic cyclohexane derivatives | Chemistry; Metallurgy | 4 | Active |
| US4399145A | Lactams Compositions and pharmaceutical methods of use | Human Necessities | 3 | Expired |
| US8288430B2 | Spiro(5.5)undecane derivatives | Chemistry; Metallurgy | 2 | Active |
| US7064236B2 | Substituted 1-aryl-but-3-enylamine and 1-aryl-but-2-enylamine compounds | Chemistry; Metallurgy | 1 | Expired |
| US6909017B2 | Method for isolating and purifying (1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol | Chemistry; Metallurgy | 1 | Expired |
| US7217729B2 | Substituted indoles, process for the production thereof and use thereof for combatting pain | Chemistry; Metallurgy | 0 | Expired |
| US9725459B2 | 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I | Human Necessities | 0 | Active |
| US4199573A | Diazaborines and drug compositions | Chemistry; Metallurgy | 0 | Expired |
| US7427370B2 | Method for the production of Grignard compounds | Chemistry; Metallurgy | 0 | Expired |
| US7435825B2 | Hydrates of optionally substituted 2-(2-pyridinyl) methylthio-1H-benzimidazoles and process for the production thereof | Chemistry; Metallurgy | 0 | Expired |
| US7557218B2 | Hydrates of optionally substituted 2-(2-pyridinyl) methylthio-1H-benzimidazoles and process for the production thereof | Chemistry; Metallurgy | 0 | Active |
| US10093691B2 | Crystallization method and bioavailability | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.